United States

UK pharmaceutical firm GlaxoSmithKline (GSK) has reiterated its 'diversify to de-risk' strategy during October 2008 with three medium size acquisitions, all focused away from traditional... 2008-10-24

Merck & Co has announced another wave of job cuts in response to declining profits. By 2012, Merck will eliminate 7,200 positions including 400 vacancies, or 12% of its global... 2008-10-24

US giant Pfizer and Belgium's leading biopharmaceutical company UCB have set up a new company, Cyclofluidics, which will aim to accelerate the drug discovery process. The joint venture... 2008-10-22

US-based Bristol-Myers Squibb (BMS)'s decision to reduce its exposure to two of the most challenging emerging markets suggests that it has lost its appetite for risk. BMS has sold... 2008-10-16

Pharmaceutical and healthcare industry campaign donations during the current US presidential election cycle have surpassed US$21.6mn, according to data released by the Federal Election... 2008-10-16

In the latest bold move in Pfizer's restructuring project, which began in early 2007 with CEO Jeffrey Kindler's 'Our Path Forward' plan, the company has reorganised its business into... 2008-10-09

Economic events have overshadowed healthcare in the US presidential election campaigns of Barack Obama and John McCain of late. However, McCain brought the issue back to the fore... 2008-10-09

As direct-to-consumer (DTC) advertising becomes more prevalent in the medical device industry, so the practice is coming under increasing scrutiny by lawmakers. The US Senate Special... 2008-10-08

US-based Perrigo has acquired Mexico's Laboratorios Diba for around US$25mn in cash. Laboratorios Diba operates a manufacturing plant in Guadalajara and markets around 50 products... 2008-10-07

Demonstrating the importance that big pharma is placing on a strong pipeline as it heads into the patent cliff, Eli Lilly has gazumped rival suitor Bristol-Myers Squibb (BMS) with... 2008-10-07